Brings complementary capabilities in India to address patient populations most at risk
- Details
- Category: Genzyme
Genzyme Corp. (Nasdaq: GENZ), a global leader in biotechnology, and Medicines for Malaria Venture (MMV), a not-for-profit virtual research and development (R&D) organization dedicated to reducing the burden of malaria, announced a new collaboration with India's Advinus Therapeutics Ltd.
Alpharma Responds To Unsolicited Proposal By King Pharmaceuticals, Inc.
- Details
- Category: Financial
Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, confirmed that it received an unsolicited, non-binding proposal from King Pharmaceuticals, Inc. (NYSE: KG) to acquire all of the outstanding shares of Alpharma for $33.00 per share in cash. Alpharma said that proposal was identical in all material respects to two prior proposals made privately by King to the company.
King Proposes Acquisition of Alpharma for $33 Per Share in Cash
- Details
- Category: Financial
King Pharmaceuticals, Inc. (NYSE: KG) announced that it has submitted to the Board of Directors of Alpharma Inc. (NYSE: ALO) a proposal to acquire all of the outstanding shares of common stock of Alpharma for $33.00 per share in cash. The proposal is not conditioned on financing.
New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer
- Details
- Category: Bayer
Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. announced the start of a Phase III study with Nexavar® (sorafenib) tablets in liver cancer. The randomized, double-blind, placebo-controlled study is evaluating Nexavar as an adjuvant therapy for patients with hepatocellular carcinoma (HCC), or primary liver cancer.
Novo Nordisk joins the Call to Action for gender equality
- Details
- Category: Novo Nordisk
Yesterday, the Danish Minister for Development Cooperation Ms Ulla Tørnæs handed over a torch to Executive Vice President Lise Kingo, Novo Nordisk, at a ceremony in Copenhagen. With the torch Ms Tørnæs makes a Call to Action to leaders from around the world to help accelerate progress on the Millennium Development Goal 3 (MDG3): To empower women and promote gender equality.
DAIICHI SANKYO continues its expansion in Germany and Europe
- Details
- Category: Daiichi Sankyo
At the beginning of August, DAIICHI SANKYO DEUTSCHLAND GmbH is planning to take over most of the sales force for primary-care physicians in Germany used by Merck Pharma GmbH and to integrate them into the existing sales structure. The agreement between the German subsidiary of the third-largest Japanese pharmaceutical group and the Darmstadt-based company will affect about 130 employees.
Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE: BMY) and PDL BioPharma, Inc. (NASDAQ: PDLI) announced an agreement for the global development and commercialization of PDL BioPharma's anti-CS1 antibody, elotuzumab, previously known as HuLuc63, currently in Phase I development for multiple myeloma.
More Pharma News ...
- Nycomed - strong results in second quarter 2008
- Divestment of four Roche pharmaceutical products to Meda
- AstraZeneca and Abbott Expand Relationship to Include Co-Promotion of CRESTOR®
- Teva Reports Second Quarter 2008 Results - Record Quarterly Sales of $2,823 Million
- IAFF Launches Smoking Cessation Campaign with Pfizer
- Boehringer Ingelheim continued to post strong growth in local currencies in the first half of 2008
- Grindeks profit reaches 5 million lats in the first half of 2008